Advanced Liver Fibrosis in IFALD: Lessons Learned from Intestinal Transplant Patients
Advanced Liver Fibrosis in IFALD
Adult
Pathophysiology, Clinical Manifestation and Management of IFALD in Adults
- Review the pathogenesis of IFALD
- Discuss diagnostic strategies in adults with intestinal failure
- Review approaches for prevention and treatment of IFALD
CIIRTA 2025 Presents: LIFT-ECHO Live!
As part of CIIRTA 2025, LIFT-ECHO will be hosting a special in-person session, featuring a didactic presentation for Dr. Simon Gabe entitled "Mistakes to Avoid In Intestinal Failure" followed by one adult and one pediatric case presenation.
Behind the Data: Methodology of Metabolic Balance Studies
- Understand the methodology used to conduct metabolic balance studies in the EASE 5 trial of Glepaglutide.
This supplementary video complements the June 3, 2025 didacic presentation, "Metabolic Balance Studies in Intestinal Failure"
UCSF Rosenman Institute Presents: Dr. Sanjeev Arora’s Vision Behind Project ECHO
Hear from Dr. Sanjeev Arora, Founder and Executive Director of Project ECHO, as he sits down with the Health Technology Podcast to discuss the vision behind his transformative movement.
From the UCSF Rosenman Institute website:
Mistakes to Avoid in Managing Intestinal Failure
- Describe the principles in managing chronic intestinal failure
- Summarize the common pitfalls in managing CIF
- Summarize outcomes for CIF
Metabolic Balance Studies in Intestinal Failure
- Understand the role of metabolic balance studies in intestinal failure.
- Interpret metabolic data to guide nutritional management.
- Apply metabolic study findings to optimize patient care.
Individualizing Goals of GLP-2 Based on Anatomy
- Understand the role of anatomy in GLP-2 therapy.
- Align GLP-2 treatment goals with individual anatomical features.
- Optimize GLP-2 outcomes through personalized care plans.
Avoiding Use of Long Term PN in Patients without Intestinal Failure
- Identify criteria for diagnosing intestinal failure.
- Explore strategies to minimize unnecessary PN use.
- Promote multidisciplinary care to optimize nutrition.
What Have We Learnt About GLP-2 Use: The French National Experience
- Review the French National experience with GLP-2 in intestinal failure management.
- Analyze the outcomes and insights gained from GLP-2 use in French cohort studies.
- Discuss the implications of the French experience for future GLP-2 treatment strategies.
